Proteomic analysis of cerebrospinal fluid for
relapsing-remitting multiple sclerosis and clinically isolated
syndrome

J 2016

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome

PAVELEK, Zbyšek; Oldřich VYŠATA; Vojtěch TAMBOR; Kristýna PIMKOVÁ; Dai Long VU et. al.

Základní údaje

Originální název

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome

Autoři

PAVELEK, Zbyšek; Oldřich VYŠATA; Vojtěch TAMBOR; Kristýna PIMKOVÁ; Dai Long VU; Kamil KUČA; Pavel ŠTOURAČ a Martin VALIŠ

Vydání

Biomedical Reports, Athens, Spandidos Publications, 2016, 2049-9434

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Řecko

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/16:00093167

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.3892/br.2016.668

UT WoS

000379957300007

EID Scopus

2-s2.0-84989848724

Klíčová slova anglicky

multiple sclerosis; clinically isolated syndrome; cerebrospinal fluid; proteomic analysis; biomarkers; proteins

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 25. 1. 2017 12:12, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Early diagnosis and treatment of multiple sclerosis (MS) in the initial stages of the disease can significantly retard its progression. The aim of the present study was to identify changes in the cerebrospinal fluid proteome in patients with relapsing-remitting MS and clinically isolated MS syndrome who are at high risk of developing MS (case group) compared to healthy population (control) in order to identify potential new markers, which could ultimately aid in early diagnosis of MS. The protein concentrations of each of the 11 case and 15 control samples were determined using a bicinchoninic acid assay. Nanoscale liquid chromatography coupled with tandem mass spectrometry was used for protein identification. Proteomics data were processed using the Perseus software suite and R. The results were filtered using the Benjamini-Hochberg procedure for the false discovery rate (FDR) correction (FDR<0.05). The results showed that, 26 proteins were significantly dysregulated in case samples compared to the controls. Nine proteins were found to be significantly less abundant in case samples, while the abundance of 17 proteins was significantly increased in case samples compared to controls. Three of the proteins were previously linked to RR MS, including immunoglobulin (Ig) gamma-1 chain C region, Ig heavy chain V-III region BRO and Ig kappa chain C region. Three proteins that were uniquely expressed in patients with RR MS were identified and these proteins may serve as prognostic biomarkers for identifying patients with a high risk of developing RR MS.

Citovat

PAVELEK, Zbyšek; Oldřich VYŠATA; Vojtěch TAMBOR; Kristýna PIMKOVÁ; Dai Long VU; Kamil KUČA; Pavel ŠTOURAČ a Martin VALIŠ. Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome. Biomedical Reports. Athens: Spandidos Publications, 2016, roč. 5, č. 1, s. 35-40. ISSN 2049-9434. Dostupné z: https://doi.org/10.3892/br.2016.668.

@article{1369457,
   author = {Pavelek, Zbyšek and Vyšata, Oldřich and Tambor, Vojtěch and Pimková, Kristýna and Vu, Dai Long and Kuča, Kamil and Štourač, Pavel and Vališ, Martin},
   article_location = {Athens},
   article_number = {1},
   doi = {https://doi.org/10.3892/br.2016.668},
   keywords = {multiple sclerosis; clinically isolated syndrome; cerebrospinal fluid; proteomic analysis; biomarkers; proteins},
   language = {eng},
   issn = {2049-9434},
   journal = {Biomedical Reports},
   title = {Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome},
   volume = {5},
   year = {2016}
}

TY  - JOUR
ID  - 1369457
AU  - Pavelek, Zbyšek - Vyšata, Oldřich - Tambor, Vojtěch - Pimková, Kristýna - Vu, Dai Long - Kuča, Kamil - Štourač, Pavel - Vališ, Martin
PY  - 2016
TI  - Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
JF  - Biomedical Reports
VL  - 5
IS  - 1
SP  - 35-40
EP  - 35-40
PB  - Spandidos Publications
SN  - 20499434
KW  - multiple sclerosis
KW  - clinically isolated syndrome
KW  - cerebrospinal fluid
KW  - proteomic analysis
KW  - biomarkers
KW  - proteins
N2  - Early diagnosis and treatment of multiple sclerosis (MS) in the initial stages of the disease can significantly retard its progression. The aim of the present study was to identify changes in the cerebrospinal fluid proteome in patients with relapsing-remitting MS and clinically isolated MS syndrome who are at high risk of developing MS (case group) compared to healthy population (control) in order to identify potential new markers, which could ultimately aid in early diagnosis of MS. The protein concentrations of each of the 11 case and 15 control samples were determined using a bicinchoninic acid assay. Nanoscale liquid chromatography coupled with tandem mass spectrometry was used for protein identification. Proteomics data were processed using the Perseus software suite and R. The results were filtered using the Benjamini-Hochberg procedure for the false discovery rate (FDR) correction (FDR<0.05). The results showed that, 26 proteins were significantly dysregulated in case samples compared to the controls. Nine proteins were found to be significantly less abundant in case samples, while the abundance of 17 proteins was significantly increased in case samples compared to controls. Three of the proteins were previously linked to RR MS, including immunoglobulin (Ig) gamma-1 chain C region, Ig heavy chain V-III region BRO and Ig kappa chain C region. Three proteins that were uniquely expressed in patients with RR MS were identified and these proteins may serve as prognostic biomarkers for identifying patients with a high risk of developing RR MS.
ER  -

PAVELEK, Zbyšek; Oldřich VYŠATA; Vojtěch TAMBOR; Kristýna PIMKOVÁ; Dai Long VU; Kamil KUČA; Pavel ŠTOURAČ a Martin VALIŠ. Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome. \textit{Biomedical Reports}. Athens: Spandidos Publications, 2016, roč.~5, č.~1, s.~35-40. ISSN~2049-9434. Dostupné z: https://doi.org/10.3892/br.2016.668.

Přehled o publikaci